Aleena Banerji, MD

Aleena Banerji, MD, professor at Harvard Medical School and director of clinical care at the Center for Drug and Vaccine Allergy at Massachusetts General Hospital.

Articles by Aleena Banerji, MD

HAE in 2026: New Therapies, Updated Guidelines, the Case for Early Treatment

ByMauro Cancian, MD, PhD,Markus Magerl, MD,Aleena Banerji, MD

May 11th 2026

Experts weigh in on a rapidly evolving treatment landscape, from a first-line oral option to a one-time CRISPR therapy showing 87% attack reduction.

Single-Dose Lonvo-z Cuts HAE Attacks by 87% in Phase 3 Trial, With Aleena Banerji, MD

ByAleena Banerji, MD

April 27th 2026

Phase 3 HAELO data show an 87% reduction in hereditary angioedema attack rates with a one-time CRISPR therapy. Banerji discusses efficacy, safety, and durability.